AG
TPTX
Artal Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-250,000
| Closed | -$11.9M | – | 155 |
|
2021
Q4 | $11.9M | Sell |
250,000
-100,000
| -29% | -$4.77M | 0.32% | 59 |
|
2021
Q3 | $23.3M | Hold |
350,000
| – | – | 0.52% | 42 |
|
2021
Q2 | $27.3M | Buy |
350,000
+37,300
| +12% | +$2.91M | 0.55% | 35 |
|
2021
Q1 | $29.6M | Sell |
312,700
-37,300
| -11% | -$3.53M | 0.52% | 35 |
|
2020
Q4 | $42.6M | Buy |
350,000
+25,000
| +8% | +$3.05M | 0.92% | 26 |
|
2020
Q3 | $28.4M | Sell |
325,000
-25,000
| -7% | -$2.18M | 0.69% | 28 |
|
2020
Q2 | $22.6M | Buy |
350,000
+50,000
| +17% | +$3.23M | 0.63% | 32 |
|
2020
Q1 | $13.4M | Hold |
300,000
| – | – | 0.57% | 34 |
|
2019
Q4 | $18.7M | Sell |
300,000
-100,000
| -25% | -$6.23M | 0.72% | 24 |
|
2019
Q3 | $15M | Buy |
400,000
+200,000
| +100% | +$7.52M | 0.6% | 29 |
|
2019
Q2 | $8.14M | Buy |
+200,000
| New | +$8.14M | 0.33% | 50 |
|